TABLE 1.
Composition of the tested vaccine formulations
| Formulation | Content | Vol (ml) (application method)a |
|---|---|---|
| HA50FA | 50μg rHA0 + Freund adjuvant (1/1, vol/vol) | 0.15 (s.c.) |
| HA100Poly | 100μg rHA0 + Polygen adjuvant (12%, vol/vol) | 0.15 (i.m.) |
| HA50Bay | 50 μg rHA0 + 5 μg BAY98-7089 adjuvant | 0.15 (i.m.) |
| HA100Bay | 100 μg rHA0 + 5 μg BAY98-7089 adjuvant | 0.15 (i.m.) |
| Bay98 | 20 μg BAY98-7089 | 0.1 (i.m.) |
| Refvac | Inactivated, complete H5N2 virus | 0.5 (i.m.) |
| negCo | Negative control |
a
s.c., subcutaneously; i.m., intramuscularly.